{"DataElement":{"publicId":"7485592","version":"1","preferredName":"Maximum Soluble Serum Interleukin-2 Receptor Subunit Alpha Measurement Laboratory Procedure Outcome 0 Decimal Place Value","preferredDefinition":"The 0 decimal place numeric laboratory value measured, assigned or computed related to the assessment of the maximum soluble serum interleukin-2 receptor subunit alpha measured by a laboratory test.","longName":"7485591v1.0:5958603v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7485591","version":"1","preferredName":"Maximum Soluble Serum Interleukin-2 Receptor Subunit Alpha Measurement Laboratory Procedure Outcome","preferredDefinition":"the largest possible quantity or degree._Capable of being dissolved in some solvent._An immunoassay that is used to determine the amount of soluble interleukin-2 receptor subunit alpha in a patient serum sample. High levels of the soluble form of the receptor can be indicative of hematological malignancies and other neoplastic disorders._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action.","longName":"7485589v1.0:2224045v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"7485589","version":"1","preferredName":"Maximum Soluble Serum Interleukin-2 Receptor Subunit Alpha Measurement Laboratory Procedure","preferredDefinition":"the largest possible quantity or degree.:Capable of being dissolved in some solvent.:An immunoassay that is used to determine the amount of soluble interleukin-2 receptor subunit alpha in a patient serum sample. High levels of the soluble form of the receptor can be indicative of hematological malignancies and other neoplastic disorders.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C25564:C64364:C96484:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maximum","conceptCode":"C25564","definition":"The largest possible quantity or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Soluble","conceptCode":"C64364","definition":"Capable of being dissolved in some solvent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Serum Interleukin-2 Receptor Subunit Alpha Measurement","conceptCode":"C96484","definition":"An immunoassay that is used to determine the amount of soluble interleukin-2 receptor subunit alpha in a patient serum sample. High levels of the soluble form of the receptor can be indicative of hematological malignancies and other neoplastic disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CF8693-9681-1AF6-E053-4EBD850ADCE8","latestVersionIndicator":"Yes","beginDate":"2020-10-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-29","modifiedBy":"ONEDATA","dateModified":"2020-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224045","version":"1","preferredName":"Outcome","preferredDefinition":"A phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F061C-D115-4EFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CF8693-968F-1AF6-E053-4EBD850ADCE8","latestVersionIndicator":"Yes","beginDate":"2020-10-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-29","modifiedBy":"MALUMK","dateModified":"2021-01-28","changeDescription":"Released. 01/28/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5958603","version":"1","preferredName":"Outcome 0 Decimal Place Value","preferredDefinition":"The result of an action._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"5958603v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5958602","version":"1","preferredName":"Outcome Integer::0 Decimal Place Value","preferredDefinition":"The result of an action.:A number with no fractional part, including the negative and positive numbers as well as zero.::0:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C20200:C45255::0:C42646:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58758590-9033-79A4-E053-F662850A7F2A","latestVersionIndicator":"Yes","beginDate":"2017-09-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-09-05","modifiedBy":"ONEDATA","dateModified":"2017-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"58758590-9044-79A4-E053-F662850A7F2A","latestVersionIndicator":"Yes","beginDate":"2017-09-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-09-05","modifiedBy":"NYCHM","dateModified":"2017-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CPST_TOX_max_sil2ra_0dec_val","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the value of the max","type":"Preferred Question Text","description":"What was the value of the maximum soluble serum interleukin-2 receptor subunit alpha?","url":null,"context":"NHLBI"},{"name":"Maximum soluble interleukin-2 receptor alpha:","type":"Application Standard Question Text","description":"Maximum soluble interleukin-2 receptor alpha:","url":null,"context":"NHLBI"},{"name":"Maximum soluble interleukin-2 receptor alpha:","type":"Alternate Question Text","description":"Maximum soluble interleukin-2 receptor alpha:","url":null,"context":"NHLBI"},{"name":"Maximum soluble interleukin-2 receptor α:","type":"Alternate Question Text","description":"Maximum soluble interleukin-2 receptor α:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CEA903-ECC8-5638-E053-4EBD850A4BDA","latestVersionIndicator":"Yes","beginDate":"2020-10-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-29","modifiedBy":"MALUMK","dateModified":"2021-01-28","changeDescription":"Released. 01/28/2021 KMM; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}